Resolian is a global contract research organization (CRO) supporting pharmaceutical and biotech companies with specialized bioanalytical and analytical sciences solutions. Over 500 experts across the U.S., U.K., China, and Australia deliver quality results, ensuring the highest standard of regulatory compliance throughout the drug development continuum.
Resolian’s specialized solutions include small and large molecule LC-MS/MS bioanalysis, PK immunoassays for large molecules, immunogenicity, biomarkers, cell-based assays, drug metabolism/pharmacokinetics (DMPK), and CMC analytical and materials science. Dedicated laboratories equipped with state-of-the-art technology meet the needs of preclinical and clinical programs at any scale.
For more information please see https://www.linkedin.com/company/resolian/home/
Resolian’s specialized solutions include small and large molecule LC-MS/MS bioanalysis, PK immunoassays for large molecules, immunogenicity, biomarkers, cell-based assays, drug metabolism/pharmacokinetics (DMPK), and CMC analytical and materials science. Dedicated laboratories equipped with state-of-the-art technology meet the needs of preclinical and clinical programs at any scale.
For more information please see https://www.linkedin.com/company/resolian/home/
Riverlabs is a new and exciting 28-acre life sciences campus, ideally situated at the centre of the ‘Golden Triangle’ in Ware, Hertfordshire. 440,000 sq ft (GIA) will be available in three phases:
• The most affordable, existing, purpose-built R&D space in the ‘Golden Triangle’. An intelligent refresh will transform existing labs into a modern, welcoming and sustainable working environment with staff wellbeing at its heart.
• Available for fit-out in January 2023, Riverlabs 1 provides 141,423 sq ft (GIA) of ready-built, affordable, wet laboratory and write-up space.
• Available for fit-out in May 2023, Riverlabs 2 provides 219,900 sq ft (GIA) of ready-built, affordable, wet laboratory and write-up space.
• Set within a unique, open campus environment enjoying natural waterfront to the River Lea. 15 acres of open green space plus sports club, tennis courts, cricket pitch, five-a-side football, access to water-based activities, river walks and nature on the doorstep.
• Perfectly positioned in an established life sciences ecosystem. Home to GSK for 50+ years, and within a 45-minute radius of major life science clusters in London, Cambridge and Stevenage, providing a huge pool of life sciences talent to recruit from.
To find out more visit https://www.riverlabsware.com
• The most affordable, existing, purpose-built R&D space in the ‘Golden Triangle’. An intelligent refresh will transform existing labs into a modern, welcoming and sustainable working environment with staff wellbeing at its heart.
• Available for fit-out in January 2023, Riverlabs 1 provides 141,423 sq ft (GIA) of ready-built, affordable, wet laboratory and write-up space.
• Available for fit-out in May 2023, Riverlabs 2 provides 219,900 sq ft (GIA) of ready-built, affordable, wet laboratory and write-up space.
• Set within a unique, open campus environment enjoying natural waterfront to the River Lea. 15 acres of open green space plus sports club, tennis courts, cricket pitch, five-a-side football, access to water-based activities, river walks and nature on the doorstep.
• Perfectly positioned in an established life sciences ecosystem. Home to GSK for 50+ years, and within a 45-minute radius of major life science clusters in London, Cambridge and Stevenage, providing a huge pool of life sciences talent to recruit from.
To find out more visit https://www.riverlabsware.com
RxCelerate is an outsourced drug development platform specialising in bespoke experimental design with data-rich end-points. We can drive your asset through drug discovery, medicinal chemistry, preclinical research and beyond, maximising your chances of reaching the clinic. RxCelerate offers comprehensive investigation packages and stand-alone assays with in-built flexibility, making it the perfect partner for both virtual, asset-centric companies and large pharmaceutical companies seeking to outsource elements of their project. We combine client consultation with in-house expertise to ensure that our in vitro design and preclinical models are robust and information rich, improving both compund progression and translational capacity.
Sagittarius IP is a firm of Chartered and European Patent Attorneys who specialise in chemical, pharmaceutical and biotechnology subject matter. We provide the following services: drafting, filing and prosecution of patent applications and representation before the UK and European Patent Offices, including oppositions and other contentious work; filing of international patent applications (PCT) and control of worldwide patent prosecution; advice on IP strategy; freedom to operate investigation; IP due diligence; and IP education. Sagittarius IP was set up in 2002 and opened a Cambridge office in 2009.
No data available
We are a science communications agency for the life science, biotech, healthcare and engineering sectors - a talented team of communicators, marketers and designers with a shared passion for scientific discovery.
Our clients include start-ups, scale-ups and global players from all parts of the innovation ecosystem; we all share a common purpose - a vision to shape the future.
We’ve spent our careers working closely with entrepreneurs and innovators to connect brilliant ideas with audiences globally.
We think creatively, de-code the complex and bring innovative science to life.
Whether you are a biotech start-up wanting to build a brand and establish your reputation or a more established player in need of PR support or a digital marketing campaign, we’d love to hear from you.
Our clients include start-ups, scale-ups and global players from all parts of the innovation ecosystem; we all share a common purpose - a vision to shape the future.
We’ve spent our careers working closely with entrepreneurs and innovators to connect brilliant ideas with audiences globally.
We think creatively, de-code the complex and bring innovative science to life.
Whether you are a biotech start-up wanting to build a brand and establish your reputation or a more established player in need of PR support or a digital marketing campaign, we’d love to hear from you.
eLabNext is your partner in lab digitization. Their centralized Digital Lab Platform enables scientists to optimize laboratory processes and accelerate research discoveries. Maximize capabilities by integrating free add-ons from Marketplace or develop your own with eLab APIs & SDKs. Their team of friendly experts are always ready to assist you and your team. eLabNext is a brand of Bio-ITech BV, part of Eppendorf Group.
Watch their video here:
https://youtu.be/bdQzm732k2Q
Watch their video here:
https://youtu.be/bdQzm732k2Q
No data available
No data available
Sepsis Research exists to stop sepsis stealing lives by driving research, policy change and public awareness at scale. Sepsis is the leading cause of preventable death worldwide with emerging evidence suggesting cases could be as high as 15 million annually in the UK and 166 million globally.
With sepsis now a top NHS priority, the charity sits at the heart of a UK-wide coalition of patients, families, industry, the NHS, government, academia and philanthropy. It delivers research that changes practice and outcomes, influences national health policy and leads joint awareness campaigns with governments across the UK.
With sepsis now a top NHS priority, the charity sits at the heart of a UK-wide coalition of patients, families, industry, the NHS, government, academia and philanthropy. It delivers research that changes practice and outcomes, influences national health policy and leads joint awareness campaigns with governments across the UK.